Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block ...
News-Medical.Net on MSN
Researchers develop nasal antiviral platform using AI technology to block flu and COVID-19
Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block ...
A South Korean research team has successfully developed an antiviral platform using artificial intelligence (AI) to overcome ...
Polyrizon stock is up on new data showing its naloxone hydrogel formulation has stronger and longer-lasting mucosal retention ...
How does the immune system fight pathogens? The immune system has two distinct components: mucosal and circulatory. The mucosal immune system provides protection at the mucosal surfaces of the body.
These findings reinforce the potential of Polyrizon’s Trap & Target™ technology to deliver an innovative intranasal naloxone product that combines enhanced mucosal residence time with the essential ...
E-cigarette users and smokers had significantly higher amounts of Staphylococcus aureus in their respiratory microbiome than nonsmokers, and microbial diversity differed by sex, according to a new ...
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting ...
Many things can block normal nasal drainage, including excess mucus from allergies or an infection, but experts say there are options to help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results